Bevacizumab Plus Capecitabin vs S-1 as Maintenance Treatment Following First-line Chemotherapy in the Patients With Advanced Colorectal Adenocarcinoma
Clinical trial NCT03708536 · WITHDRAWN
Trial details
- NCT number
- NCT03708536
- Sponsor
- Fujian Cancer Hospital
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-01
- Primary completion
- 2021-11-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.